Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

R Rockett; K Basile; S Maddocks; W Fong; JE Agius; J Johnson-Mackinnon; A Arnott; S Chandra; M Gall; J Draper; E Martinez; EM Sim; C Lee; C Ngo; M Ramsperger; AN Ginn; Q Wang; M Fennell; D Ko; HL Lim; N Gilroy; MVN O'Sullivan; SCA Chen; J Kok; DE Dwyer; V Sintchenko

Journal article

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

R Rockett, K Basile, S Maddocks, W Fong, JE Agius, J Johnson-Mackinnon, A Arnott, S Chandra, M Gall, J Draper, E Martinez, EM Sim, C Lee, C Ngo, M Ramsperger, AN Ginn, Q Wang, M Fennell, D Ko, HL Lim Show all

New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2022

DOI: 10.1056/NEJMc2120219

Abstract

Resistance Mutations after Sotrovimab Use Among the first 100 patients who received sotrovimab, a monoclonal antibody directed against SARS-CoV-2, at a center in Australia, 8 had persistently posit...

University of Melbourne Researchers

Alicia Arnott Author

Related Projects (1)

AUSTRALIAN PARTNERSHIP FOR PREPAREDNESS RESEARCH ON INFECTIOUS DISEASE EMERGENCIES (APPRISE)

We have assembled national experts in clinical, laboratory and public health research to ensure Australia is equipped for a coordinated, eff..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

Supported by the Prevention Research Support Program, which is funded by the New South Wales (NSW) Ministry of Health; NSW Health Covid-19 priority funding; a grant (APPRISE 1116530) from the National Health and Medical Research Council, Australia; and a Jerry Koutts Ph.D. Scholarship (to Dr. Basile) from the Institute of Clinical Pathology and Medical Research.